chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a his mother who on 15-DEC-2008 was vaccinated with a dose of PNEUMOVAX (manufacturer unknown). After the injection an immediate sharp severe pain was described and a weekend feeling in the arm which continued until early 18-DEC-2008. The patient was following up with another physician on 19-DEC-2008, but the pain had not gone away. The reporter explained that while the vaccine was administered in the arm it was extremely high and possible into the acromial process area. His concern was the vaccine was possibly injected into the bursal sac or the intra-articular area of the shoulder. The needle size was not clear. The patient went to an orthopedic surgeon on 19-DEC-2008 and the surgeon believed the injection was intra-articular space in supraspinatus, tendon or rotator cuff. The patient did not have severe pain at the rest so the surgeon did not feel she had an infection. The patient was placed on steroids and anti-inflammatory medication. The patient was returning to the surgeon on Monday, 22-DEC-2008 and the surgeon may order an MRI. Additional information has been requested.
Information has been received from a healthcare worker referring to unspecified number of patients (age and gender were not reported). On unspecified dates patients were vaccinated with improperly stored doses of VAQTA lot # K019560, expiration date 02-JUN-2017, (dose, dose #, route and application site were not reported). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Difficulty breathing; Swelling a bit of my face; Pressure over chest; Dizziness; Weakness; Injection site pain; Injection site itchy; Tiredness; Headache; Muscle pain; Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 06Apr2021 at 13:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included supplements (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 13:30 as a single dose for COVID-19 immunisation. On 06Apr2021, the patient experienced difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain, fever and chills (subsided). Therapeutic measures were not taken as the result of adverse events. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events difficulty breathing, swelling a bit of my face, pressure over chest, dizziness and weakness, injection site pain and itchy, tiredness, headache, muscle pain was recovering at the time of this report while that of the events fever and chills was recovered on an unknown date in Apr2021.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
DOSE WITHDRAWN TWO DAYS AGO WAS GIVEN TO A PATIENT TODAY; This spontaneous report received from a pharmacist concerned a 61 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 28-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 28-JUL-2021, the subject experienced dose withdrawn two days ago was given to a patient today. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of dose withdrawn two days ago was given to a patient today was not reported. This report was non-serious.
pt recvd vax; pt devel breath holding spell w/ cry after shot; father lifted pt up; became stiff few seconds; quickly became reactive; took formula well;
Information has been received from a health professional concerning a 71 year old female with hypothyroidism and a history of gastroesophageal reflux disease who on 25-JAN-2007 was vaccinated IM with a 0.5 ml dose of Zostervax (lot #656412/1476F). Concomitant therapy included Synthroid. On 30-JAN-2007 the patient developed itching, pain and a rash, which was located on the left back. The patient was seen in the office on 31-JAN-2007 and diagnosed with shingles. There was no change in the rash from 30-JAN-2007 to 31-JAN-2007. The patient was given prescriptions for prednisone, FAMVIR and VICODIN. No laboratory tests were performed. The patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
About 11 days after getting the Moderna booster and seasonal flu shot, I developed hives (urticaria) beginning on my scalp and moving to my shoulders and then my entire body. After 2 days, I went to urgent treatment clinic to seek relief from itching and swelling. I was prescribed prednisone for 5 days, which helped slightly but it was clear that it did not cure the hives. After these 5 days, I used Benadryl and Claritin, as directed by the urgent treatment clinic doctor, to relieve symptoms for about 5 weeks.  The patches (that started out seemingly randomly and blotchy or circular) turned to looking more dermographism (skin writing) after about a week. Anywhere I touched my own skin would become itchy, red,  and raised.  It took about 6 weeks to go away significantly. Between 11/22/21 and 1/4/22, I?ve tested negative for covid 4 times on both rapid and PCR tests.
Unable to lift arm above head, some swelling & hardness at the injection site. Consulted her doctor on 4/16/10-received penicillin, then broke out in hives. 2 courses of oral steroids, ibuprofen. Went back to doctor 1 week later.
Information has been received from a physician concerning a 5 year old male who in approximately 2003 was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed 50 breakthrough lesions or less. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
Client states she felt "very hot" after vaccination and then fainted.  Client felt fine within several minutes.
A non-serious spontaneous report of administration to a pregnant female was received from a consumer concerning a 24-year-old female. The patient's medical history and concomitant medications were not reported. The patient was administered FLUMIST but did not know that she was pregnant. There was no adverse event reported to date. Treatment and reporter/sponsor causality assessments are not applicable. The reporter was asked to inform when the pregnancy has ended and also to inform if the patient experiences any adverse events during the pregnancy.
Fast heart beat; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast heart beat) and MYALGIA (Sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced HEART RATE INCREASED (Fast heart beat) and MYALGIA (Sore arm). On 19-Feb-2021, HEART RATE INCREASED (Fast heart beat) and MYALGIA (Sore arm) had resolved.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable  No concomitant medications reported by investigator  No treatment medications provided by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Non-significant follow received. Husband's email address provided.
going to get the Pfizer as a booster; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (going to get the Pfizer as a booster) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 031M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (going to get the Pfizer as a booster). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (going to get the Pfizer as a booster) had resolved.            Patient's medication included lot pf pills.  Treatment information was not provided.   This case was linked to MOD-2021-399861 (Patient Link).
Patient reports that she has been shaking with chills since for 72 hours straight since receiving the vaccine. She reports that she cannot get her body to stop shaking.
made me feel a little icky; This case was reported by a consumer via interactive digital media and described the occurrence of malaise in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included shingles vaccine (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced malaise. On an unknown date, the outcome of the malaise was unknown.   It was unknown if the reporter considered the malaise to be related to Shingles vaccine.     Additional Information: GSK receipt date: 23-AUG-2022 Reporter's Comments: This case was reported by the patient via interactive digital media. Patient had 2 shingles shots within the past year and the second one made patient feel a little icky, but it sure beats getting shingles.
IMMEDIATE ITCHING , THE SITE IS STILL SWOLLEN AND SORE LIMITED LIFT OF THE ARM.
I have been sick for the last 5 days. I've had a migraine headache for several days and been very nauseous and weak, chills, and swollen lymph nodes under my armpit. My body was very sore, it was painful to move, and I could not eat for several days.
Itchy rash, tiny red dots all over the body. Did not treat. remained for 2 days post-vaccination and decreased in severity within 48 hours.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), in Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 53 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing), notes: High Blood pressure. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 09Nov2022 at 10:00, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient previously receive a COVID-19 Vaccine. COVID vaccine details: vaccine brand=Pfizer/BioNTech, Vaccine administration time=09:00 AM, Vaccine dose number=4. Antiviral details, product=COVID-19 Treatment, brand=Pfizer, treatment start date=09Nov2022, treatment stop date=13Nov2022, lot number=GE7319, indication=Treatment of COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Abnormal heart beat, palpitation, body shaking ( tremor), felling Hot and cold.
Information has been received from a nurse referring to multiple unspecified patients. Their medical history, concurrent condition and concomitant therapy were not provided. On unknown dates, the patients were administered improperly stored with PROQUAD (strength, dose, frequency and route were unknown; lot number and expiration were: L051098/17-JUN-2017, M006102/01-AUG-2017) for prophylaxis. No adverse effects reported. The temperature excursion was 6.8 degree Fahrenheit for 45 minutes. There was no previous temperature excursion. This report was for data logger. This is one of several reports received from the same reporter. All telephone call attempts to obtain follow-up information on 11-MAY-2017 have been unsuccessful.  Additional information has been requested. Sender's Comments: US-009507513-1608USA006030: MERCK 1608USA007923: Mfr number.
hazy vision in right eye which may have begun before patient woke up. effect was moderate, as if viewing everything through a piece of plastic film or a dirty glass window. symptoms persisted until around 11:00AM that day and then subsided and have not returned.
Left leg deep vein thrombosis Patient has family history of Factor V Leiden. After the ultrasound showed DVT, the patient was subsequently tested positive for single R506Q mutation (heterozygote)
This spontaneous report was received from a pharmacist refers to a 18 year old female patient. Medical history and concurrent conditions were not reported. In 2014, the patient was vaccinated with the second dose of GARDASIL (lot number, expiration date, strength and route were not reported). Co-suspect and concomitant therapies were not reported. Pharmacist reported that in 2014, patient was in pharmacy to received second dose of GARDASIL. Patient had received first dose of GARDASIL in 2012 (reported as about two years ago). No adverse effect was reported. Additional information has been requested.
The pt received vax 22 weeks after LMP. An ultrasound confirmed pregnancy. The pt sought unspecified medical attention. She took prenatal vitamins during the pregnancy. A targeted fetal survey at 25 weeks from LMP was unremarkable, however fluid was increased. There were no pregnancy complications. On 2/16/99, the pt gave birth to a normal healthy female.
30 minutes after I was given the vaccine I felt my left temple become warm and then numb.  40 minutes after receiving the vaccine my left cheekbone and left jaw felt numb, like I had a Novocain shot from the dentist.
Chills, muscle aches, severe pain, low grade fever of 99.9F, cough, shortness of breath, crackles in lungs, pneumonia on day 12 of illness, being treated with prednisone for 12 days and zithromax for five with an albuterol inhaler being used 4 times a day.
Extreme pain in shot area of arm that worsened on the day of injection and stayed bad for an additional day, with difficulty raising arm up above head. It started to subside after that, but arm felt weaker than other arm when doing strenuous things like lifting light weights, and would have pain in shoulder after the activity. I occasionally feel pain come and go in the shot area atimes. Also had light chest pain that came and went throughout the day for about three weeks after the shot.
c/o redness & induration @ inj site;rt deltoid mom instructed to give DPH as directed, apply compress & given APAP as directed from temp;
pt recvd vax for prophylaxis;p/2 doses,exp muscle aches,malaise,resolved w/in 24 hrs;1 day p/ dose 3,exp local discomfort at inject site w/swelling at inject site;red,inflammed,very warm to touch;sl fever;c/o sever muscle joint/bone pain;ha
Post third vax, vaccinee experienced itching and pain at injection site which progressed to generalized itching. The most recent information reports the conditionn of the pt as unknown.
Difficulty swallowing 2:00 AM - 6:00 PM. Attempts to swallow induced choking and belching. Total fluid intake during that period: 3 oz. water at room temperature (68 F). Headache 2:00 AM - 7:00 PM.  Strong pressure on entire skull. Unable to swallow medication until 6:00 PM (325 mg acetaminophen). Dizziness, difficulty walking, nausea. Headache returned on 1/30, 1/31, 2/2, 2/4, 2/7, 2/11.
A 19 year old female patient with no past medical history received an intramuscular injection of MENACTRA (lot number U2665AA) in the left deltoid on 29 July 2008, the patient also received MENOMUNE four years prior (lot number not provided).  On 30 July 2008 the patient had a large induration.  "the size of a baseball ", at the left deltoid injection site.  She also had a large amount of lymph node swelling in the left clavicular area.  The patient complained of pain at the injection site.  She was being monitored by her doctor.  She was advised to use an ice pack and IBUPROFEN.  The patient did not recover from the events at the time of the report.  Follow-up information received from a health care professional on 25 August 2008.  It was confirmed that the patient is male, not female.  It was reported that the patient's symptoms of enlarged lymph nodes, injection site reaction and inflammation at site started approximately four to five hours after the MENACTRA vaccine was given on 29 July 2008 at 4:45 PM. The symptoms subsided gradually, lasting three to four days.  The patient had not experienced any adverse events following prior vaccination.
Mom of patient called the pharmacy on 7/20 to report that at 4am that morning, patient woke up with 100.9 degree Fahrenheit fever and large movement shaking that was uncontrollable. She also started having a feeling of numbness in her face as well as tingling in her hands and feet. Several hours later she had headache and upset stomach only.
Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 11May2021 20:00 (Lot number: Er8736) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Celiac disease" (unspecified if ongoing); "gluten snesitivity" (unspecified if ongoing); "highblood pressure" (unspecified if ongoing); "Demylating disease" (unspecified if ongoing); "joint and muscle pain" (unspecified if ongoing); "joint and muscle pain" (unspecified if ongoing); "possibly autoimmune from celiac disease," (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: HYDROXYCHLOROQUINE; AMLODIPINE BESYLATE. Past drug history included: Gluten, reaction(s): "allergy". Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: Ew0162, Location of injection: Arm Right, Vaccine Administration Time: 08:00 PM), administration date: 19Apr2021, when the patient was 47 years old, for COVID-19 Immunization. The following information was reported: HEADACHE (non-serious) with onset May2021, outcome "recovered" (May2021), described as "Headache".  Additional information: Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. After dose 2, headache for 1 day. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device Date was 30Jan2022.  No follow-up attempts are possible. No further information is expected.
Shortness of breath, chest tightness, insufficient inhilation, air hunger. Started roughly 2-3 days after and was intermittent until 5/15/2021. Dyspnea is getting progressively worse with clear lung sounds
Pt given Menveo vaccine at 11:50 am; 11:55 am c/o mild dizziness, pt layed down; 11:58 am mild nausea, diaphoresis, and pale, BP 90/50, HR 56 (Conditional Athlete);   12:03 pm BP 92/54, HR 56; 12:07 pm BP 96/60, HR 70; 12:12 BP 96/60, HR 60; 12:22pm BP 94/64, HR 60; 12:32 pm BP 94/62, HR 62; 12:42 pm BP 94/62, HR 60.  No treatment initiated.  Pt accompanied by mother and brother and left clinic once feeling better.
Headache, Myalgia, Fever, Nausea Vomiting, Fatigue, chills Narrative:
Sore arm, dizziness, rash lasting unitl present day. Was sore.
Patient reported feelings of malaise as well as injection site reaction and a rash on the trunk/torso.
Information has been received from a Medical Assistant concerning a patient who on 28-JUL-2010, was inadvertently vaccinated SQ with a dose of VARIVAX (Merck) (Lot#: not reported) instead of ZOSTAVAX (Merck). No adverse effect was reported. It was unspecified if the patients sought medical attention. This is one of several reports received from the same source. No further information is available.